|
1
|
Priya Krishna S, Nagare RP, Sneha VS,
Sidhanth C, Bindhya S, Manasa P and Ganesan TS: Tumour
angiogenesis-Origin of blood vessels. Int J Cancer. 139:729–735.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang S, Zhang D and Sun B: Vasculogenic
mimicry: Current status and future prospects. Cancer Lett.
254:157–164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qiao L, Liang N, Zhang J, Xie J, Liu F, Xu
D, Yu X and Tian Y: Advanced research on vasculogenic mimicry in
cancer. J Cell Mol Med. 19:315–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Williamson SC, Metcalf RL, Trapani F,
Mohan S, Antonello J, Abbott B, Leong HS, Chester CP, Simms N,
Polanski R, et al: Vasculogenic mimicry in small cell lung cancer.
Nat Commun. 7:133222016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kirschmann DA, Seftor EA, Hardy KM, Seftor
RE and Hendrix MJ: Molecular pathways: vasculogenic mimicry in
tumor cells: diagnostic and therapeutic implications. Clin Cancer
Res. 18:2726–2732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schnegg CI, Yang MH, Ghosh SK and Hsu MY:
Induction of vasculogenic mimicry overrides VEGF-A silencing and
enriches stem-like cancer cells in melanoma. Cancer Res.
75:1682–1690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang JY, Sun T, Zhao XL, Zhang SW, Zhang
DF, Gu Q, Wang XH, Zhao N, Qie S and Sun BC: Functional
significance of VEGF-a in human ovarian carcinoma: Role in
vasculogenic mimicry. Cancer Biol Ther. 7:758–766. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karroum A, Mirshahi P, Faussat AM,
Therwath A, Mirshahi M and Hatmi M: Tubular network formation by
adriamycin-resistant MCF-7 breast cancer cells is closely linked to
MMP-9 and VEGFR-2/VEGFR-3 over-expressions. Eur J Pharmacol.
685:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao X, Ping Y, Liu Y, Chen K, Yoshimura T,
Liu M, Gong W, Chen C, Niu Q, Guo D, et al: Vascular endothelial
growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic
mimicry formation, neovascularization and tumor initiation by
glioma stem-like cells. PLoS One. 8:e571882013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang S, Fu Z, Wei J, Guo J, Liu M and Du
K: Peroxiredoxin 2 is involved in vasculogenic mimicry formation by
targeting VEGFR2 activation in colorectal cancer. Med Oncol.
32:4142015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Frank NY, Schatton T, Kim S, Zhan Q,
Wilson BJ, Ma J, Saab KR, Osherov V, Widlund HR, Gasser M, et al:
VEGFR-1 expressed by malignant melanoma-initiating cells is
required for tumor growth. Cancer Res. 71:1474–1485. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vartanian A, Stepanova E, Grigorieva I,
Solomko E, Baryshnikov A and Lichinitser M: VEGFR1 and PKCα
signaling control melanoma vasculogenic mimicry in a VEGFR2
kinase-independent manner. Melanoma Res. 21:91–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Young LS, Yap LF and Murray PG:
Epstein-Barr virus: More than 50 years old and still providing
surprises. Nat Rev Cancer. 16:789–802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang LW, Jiang S and Gewurz BE:
Epstein-Barr virus LMP1-mediated oncogenicity. J Virol. 91:912017.
View Article : Google Scholar
|
|
16
|
Kondo S, Seo SY, Yoshizaki T, Wakisaka N,
Furukawa M, Joab I, Jang KL and Pagano JS: EBV latent membrane
protein 1 up-regulates hypoxia-inducible factor 1alpha through
Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in
nasopharyngeal epithelial cells. Cancer Res. 66:9870–9877. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murono S, Inoue H, Tanabe T, Joab I,
Yoshizaki T, Furukawa M and Pagano JS: Induction of
cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is
involved in vascular endothelial growth factor production in
nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA.
98:6905–6910. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Luo F, Li L, Yang L, Hu D, Ma X,
Lu Z, Sun L and Cao Y: STAT3 activation induced by Epstein-Barr
virus latent membrane protein1 causes vascular endothelial growth
factor expression and cellular invasiveness via JAK3 And ERK
signaling. Eur J Cancer. 46:2996–3006. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang L, Liu L, Xu Z, Liao W, Feng D, Dong
X, Xu S, Xiao L, Lu J, Luo X, et al: EBV-LMP1 targeted DNAzyme
enhances radiosensitivity by inhibiting tumor angiogenesis via the
JNKs/HIF-1 pathway in nasopharyngeal carcinoma. Oncotarget.
6:5804–5817. 2015.PubMed/NCBI
|
|
20
|
Xiao L, Hu ZY, Dong X, Tan Z, Li W, Tang
M, Chen L, Yang L, Tao Y, Jiang Y, et al: Targeting Epstein-Barr
virus oncoprotein LMP1-mediated glycolysis sensitizes
nasopharyngeal carcinoma to radiation therapy. Oncogene.
33:4568–4578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu J, Wang N and Wang YJ: XRCC3 and RAD51
expression are associated with clinical factors in breast cancer.
PLoS One. 8:e721042013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Holmes K, Roberts OL, Thomas AM and Cross
MJ: Vascular endothelial growth factor receptor-2: Structure,
function, intracellular signalling and therapeutic inhibition. Cell
Signal. 19:2003–2012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hendrix MJ, Seftor EA, Seftor RE, Chao JT,
Chien DS and Chu YW: Tumor cell vascular mimicry: Novel targeting
opportunity in melanoma. Pharmacol Ther. 159:83–92. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tan LY, Mintoff C, Johan MZ, Ebert BW,
Fedele C, Zhang YF, Szeto P, Sheppard KE, McArthur GA, Foster-Smith
E, et al: Desmoglein 2 promotes vasculogenic mimicry in melanoma
and is associated with poor clinical outcome. Oncotarget.
7:46492–46508. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bissanum R, Lirdprapamongkol K, Svasti J,
Navakanitworakul R and Kanokwiroon K: The role of WT1 isoforms in
vasculogenic mimicry and metastatic potential of human triple
negative breast cancer cells. Biochem Biophys Res Commun.
494:256–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun J, Sun B, Sun R, Zhu D, Zhao X, Zhang
Y, Dong X, Che N, Li J, Liu F, et al: HMGA2 promotes vasculogenic
mimicry and tumor aggressiveness by upregulating Twist1 in gastric
carcinoma. Sci Rep. 7:22292017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Massi D, Franchi A, Paglierani M, Ketabchi
S, Borgognoni L, Reali UM and Santucci M: Vasculogenic mimicry has
no prognostic significance in pT3 and pT4 cutaneous melanoma. Hum
Pathol. 35:496–502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shirakawa K, Wakasugi H, Heike Y, Watanabe
I, Yamada S, Saito K and Konishi F: Vasculogenic mimicry and
pseudo-comedo formation in breast cancer. Int J Cancer. 99:821–828.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshizaki T, Kondo S, Wakisaka N, Murono
S, Endo K, Sugimoto H, Nakanishi S, Tsuji A and Ito M: Pathogenic
role of Epstein-Barr virus latent membrane protein-1 in the
development of nasopharyngeal carcinoma. Cancer Lett. 337:1–7.
2013. View Article : Google Scholar : PubMed/NCBI
|
